PharmaEngine Inc. (Taipei Exchange: stock code 4162.TWO) began operations in 2003, is a commercial stage pharmaceutical company dedicated to developing medicines for cancer patients. We are currently focusing on precision oncology related to DNA damage response (DDR) pathways. PEP07, an orally bioavailable small molecule CHK1 inhibitor with brain penetrating properties, is currently in Phase 1 clinical studies for Acute Myeloid Leukemia (AML), Mantle Cell Lymphoma (MCL), or advanced/metastatic solid tumors. Our preclinical pipeline includes other targets in the DDR pathways aiming to provide synergy when in combinations with chemo/radiation therapies or with other precision oncology medicines.
In the past, PharmaEngine successfully developed and out-licensed its first commercial product, ONIVYDE (liposomal irinotecan), for the treatment of metastatic pancreatic adenocarcinoma. It is also responsible for the commercialization of ONIVYDE in Taiwan.
We strongly believe in building a sustainable business and work environment with our six core values. We encourage employees to have “Sense of Urgency” and adopt “Critical Thinking” when facing dynamic environments and challenges that require rapid responses. We wish to build a work environment with “Diversity” and a space for “Continuous Learning and Growth” as we believe inclusivity and room for growth are crucial to employee welfare. “Teamwork” is crucial in new drug development and we hope through considerate communication and sharing, each member can utilize their specialties and feel valued. Lastly, we put great emphasis on helping each member achieve their individual “Work and Life Balance” in different stages of life.
For more information, please visit our company website.
Company Details
- Employees
- 30
- Founded
- -
- Address
- No. 10, Sec. 3, Minsheng East Road, 11f,taiwan, Province Of China
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- pharmaengine.com
- Keywords
- new drug development and licensing.
- HQ
- Taipei
Pharmaengine, Inc. Questions
Pharmaengine, Inc.'s website is pharmaengine.com
Pharmaengine, Inc.'s LinkedIn profile is https://tw.linkedin.com/company/pharmaengine-inc
Pharmaengine, Inc. has
30 employees.
View email and phone details for 30
employees at Pharmaengine, Inc..
Pharmaengine, Inc.'s industry is
Pharmaceutical Manufacturing
Pharmaengine, Inc.'s top competitors are
Roche,
台灣維昇藥業有限公司 Visen Pharmaceuticals (Taiwan) Ltd.,
Oep Group 友華集團,
Pharmaessentia Corp.,
Bora Pharmaceuticals,
Onward Therapeutics,
Astrazeneca Taiwan,
Abbvie,
Msd Taiwan,
友霖生技醫藥(股)公司 Orient Pharma Co., Ltd..
Pharmaengine, Inc.'s categories are Pharmaceutical Manufacturing
Pharmaengine, Inc.'s founding year is 2003
